MARIEL HAMILTON: Open Payments
NPI 1497466353 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$583 in 25 payments from 9 companies in 2025. Trend: 2023 $350 · 2024 $206 · 2025 $583
Food & beverage: $583
| Company | Payments | Amount |
|---|---|---|
| Calliditas Therapeutics US Inc. | 6 | $189 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $105 |
| Travere Therapeutics, Inc. | 4 | $84 |
| Novo Nordisk Inc | 2 | $53 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Vifor Pharma, Inc. | 2 | $35 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| Lilly USA, LLC | 1 | $22 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $20 |
Products named: TARPEYO, Kerendia, Veltassa, FARXIGA, Ozempic, Vanrafia, JARDIANCE, LOKELMA.
Industry payments across SC — which companies pay providers there.
